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   INTRODUCTION 
Autosomal dominant polycystic kidney disease (ADPKD) is the most 
common inherited renal disease (Gabow , PA, Bennet WM, Breuning MH, 
Peter DJM)  ADPKD affect approximately 500000 population in united 
states and is the most frequent genetic cause of Renal failure in adult 
accounting for 10% of patient on dialysis in the US (Torra 2008)  ADPKD in 
common hereditary condition caused  by mutation of either  PKD1, or PKD2 
and genetic basis of ADPKD has been clearly established (Scheieren et al 
2006) although name describes renal disorder the disease is systemic and 
includes both cystic and non cystic extra renal abnormalities. These include 
liver cyst, pancreatic cyst, intracranial and coronary aneurysm, mitral valve 
prolapse and possibly spontaneous arterial dissection (Demetriou et al 2000)   
The main cause of death in ADPKD are Uraemia, atherosclerosis 
affecting coronary, intracranial and peripheral arteries, sudden rupture of 
intracranial aneurysm and sepsis (Demetriou et al 2000)  ADPKD is 
phenotypically heterogeneous both between and also within affected 
families. (Gabow PA, Ravine D Walk, RG Gibson RW et al Kiemberling 
WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, PA.) The inter – familial  
variability is  explained by the well – known genetic heterogeneity with               
atleast two major genes responsible for ADPKD, and another third putative 
gene. For both major genes,  different mutations are observed in different 
 7 
 
families and to this day no single common mutation has been               
identified.(1, 2,3,4) 
Before formal diagnosis of ADPKD has been made, many of the visits 
to primary care provides like General practioner are related to complication 
associated with ADPKD, such as hypertension, abdominal pain, and urinary 
tract infection (UTI) (Torra, 2008). Since clinical symptoms usually begin in 
the third, fourth, or fifth decade of life, it is important for a primary care 
provider (PCP) to be aware of this disease and arrange diagnostic imaging or 
genetic testing to properly diagnose an individual.     
 It is one of the rare disorder, that involve the kidney it leads to major 
morbidity and mortality. When we screen the family are can detect disease 
early and delay the morbidity and mortality due to  ADPKD 
  In this study I am going to evaluate clinical profile of patient 
attending General Medicine and Nephrology Department  and the family 
screening for the above patients for early diagnosis and treatment, and  delay 
the morbidity, mortality due to ADPKD.  
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AIM OF THE STUDY 
1. Evaluation of clinical profile of Autosomal Dominant Polycystic kidney 
disease patient attending General Medicine and Nephrology                    
Out Patient / In Patient Department.  
2. Family screening of ADPKD patients. 
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REVIEW OF LITERATURE 
Autosomal dominant polycystic kidney disease was described in the 
nineteenth century in European Medical literature and Sir William Osler had 
published in the middle of 20th century in USA. Comprehensive study 
describing  the disease was published in 1957 by Dr. O,Z Dalagard reported  
in his classic doctoral thesis on the inheritance of  Polycystic kidney disease 
(PKD) as  an autosomal dominant trait.  
Because of its inheritance pattern the children of PKD patient will have a 
50% chance of inheriting the disorder. ADPKD occur in worldwide and in 
all races with prevalence estimated between 1:500 – 1:10005 Gabow. 
Etiology and pathogenesis of PKD 
 PKD 1, PKD 2, are expressed in most organs and tissues of the human 
body. The proteins that are encoded by PKD1 and PKD2, polycystin 1and 
polycystin 2, seem to function together to regulate the morphologic 
configuration of epithelial cells6. The polycystins are expresses in 
development as early as the blastocyst stage and are expressed in a broad 
array of terminally differentiated tissues. The functions of the polycystins 
have been scrutinized to the greatest extent in epithelial tissue of the kidneys 
and liver and in vascular smooth muscle. Mutations in either polycystin lead 
to a clinical phenotype recognized as ADPKD. The hallmarks of this 
inherited conditions are massively enlarged kidneys caused by the sustained 
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expansion of innumerable fluid- filled cysts  ranging in equivalent size from 
a pea to a grapefruit. Cyst arise from the nephron and collecting tubules  
They are seen with lesser frequency in the liver (approximately 80%). 
Pancreas (approximately 10 %), and arachnoids membrane (approximately 
8%).Aneurysms occur in approximately 5% of patients with ADPKD and 
with higher frequency in those with a family history of aneurysm 
(approximately 5%)  of patients with ADPKD and with higher frequency in 
those with a family history of aneurysm (approximately 20%). In >60% of 
patients, hypertension develop before the loss of renal function, and the 
average age of onset, although highly variable is approximately 30 yr7-12. 
Proteinuria, often used as surrogate marker of disease activity in other 
kidney disorders, is usually <1 g/d. Proteinuria, observed more frequently in 
those with large (mean combined renal volume 1190 ml) rather than small 
(578 ml) renal volumes, is also associated with a greater likelihood of a 
subsequent loss of renal function.13 
 The renal cysts develop in a tiny fraction of the nephrons (estimated to 
be much less than 1%)14. In ADPKD, each epithelial cell within a renal 
tubule harbors a germ-line mutation, yet only a tiny fraction of the tubules 
develop renal cysts. It is currently held that the cells are protected by the 
allele inherited from the parent without ADPKD. When this allele in 
inactivated by a somatic event (Mutation or otherwise) within a solitary renal 
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tubule cell, the cell divides repeatedly until a cyst develops with an aberrant 
growth program causing endless expansion. The severity of ADPKD is 
thought to be a direct consequence of the number of times and the frequency 
with which this cryptogenic process occurs within the kidneys over the life 
of the patient.   
Hyperplasic of renal cyst epithelial cells is unquestioned in this 
disease; however the rate of cell proliferation is slow in comparison with 
transformed and malignant neoplastic cells15. The hyperplasic cells cause an 
out- pocketing of the tubule wall, with the formation of a sacular cyst that 
fills with fluid derived from glomerular filtrate that enters from the afferent 
tubule segment. Progressive expansion eventually causes most of the 
emerging cysts to separate from the parent tubule, leaving an isolated sac 
that fills with fluid by transepithelial secretion. This isolated cyst expands 
relentlessly as a result of continued proliferation of the mural epithelium 
together with the transepithelial secretion of NaCl and water into the lumen16 
The expanding fluid – filled tumor masses elicit secondary and tertiary 
changes within the renal interstitium evidenced by thickening and lamination 
of the tubule basement membranes, infiltration of macrophage, and 
revascularization 17-19. Fibrosis within the interstitium begins early in the 
course of the disease. Cellular proliferation and fluid secretion may be 
accelerated by cAMP and growth factors such as EGF 7,16,20,21. In summary, 
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cysts function as autonomous structures and are responsible for progressive 
kidney enlargement in ADPKD.    
Diagnosis of ADPKD  
 The diagnosis of ADPKD is established primarily by imaging studies 
of the kidney. Ultrasonography is the procedure of choice in the initial 
screening, work-up and diagnosis.22 The clinical diagnostic criteria relying 
on sonographic finding have a sensitivity of nearly 100  percent. Molecular 
genetic testing by sequence analysis can be helpful when the imaging results 
are equivocal and  or when a definite diagnosis is required in a younger 
adult.23 Gene linkage analysis can be used to determine obligate ADPKD 
gene carriers, but  this method has not gained widespread clinical use and 
has many practical limitations.24  
The diagnosis of ADPKD in an individual with positive family history 
relies on imaging testing counseling should be done be testing. Renal 
ultrasound is commonly used because of price and safety. As a rule of thumb 
the minimum requirement for the diagnosis of ADPKD in  individuals less 
than 18 yrs of age 1 cyst, 18-30 yrs  of age are 2 cyst (uni / bilaleral) at age 
30-60yrs  more than 4 cysts (2 cyst in each kidney ) and age above 60 yrs  at 
least 8 cyst (4 cyst in each kidney)22 
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Cyst development and growth  
Many manifestation are directly related to development and 
enlargement of renal cyst. A study of 241 nonazotemic patients  followed 
prospectively with early MRI examination,  The Consortium of Imaging 
studies to assess the Progression of polycystic kidney disease (CRISP) has 
provide invaluable information to understand how the cyst develop and grow 
25,26 Total kidney volume and cyst volume are increased exponentially. At  
baseline total kidney volume was 1060 ± 642ml and mean increase over 3yr 
was 204 ml or 5.3%  per year. The rate of change of volume and of Right  
and left   kidney volume were strongly correlated  
Renal function abnormalities   
Impaired urinary concentrating capacity is common even at early 
stages.27 Sixty percent of children can not maximally concentrate the urine. 
Plasma vasopressin levels are increased. The vasopressin resistant 
concentrating defect is not explained by reduced C AMP or expression of 
concentration associated genes. Recent studies suggest that urinary 
concentrating defect and elevated vasopressin level may contribute to 
cytogenesis. They may contribute to glomerular hyeprtltration seen in 
children and young adult28 and to the development of hypertension and 
chronic kidney disease defective medullary trapping of ammonia and transfer 
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to the urine causes by concentrating defect may contribute to the low urine 
pH values, hypocitric aciduria and predisposition to stone formation.      
Reduced renal blood flow is another early functional defect 29 it may 
be due to changes in internal pressure to neurohumoral to local mediator or 
intrinsic vascular abnormalities. Mild to moderate persistent proteinuria may 
be found in a significant number of patients in  the middle to late stage of the 
disease. It is an indicator of progressive diseases30 patients with proteinuria 
may also excrete 31 double refractile lipid bodies (oval fat bodies)31    
Morbidity in ADPKD  
Renal hemorrhage and Hematura 
Polycystic kidneys are unusually susceptible to traumatic injury, with 
hemorrhage occurring  in approximately 60% of individuals 8,9,19,32,42. Mild 
trauma can lead to intrarenal hemorrhage or bleeding into the retroperitoneal 
space accompanied by intense pain that often requires narcotics for relief43. 
The cysts are associated with excessive angiogenesis evidenced  by fragile 
vessels stretched across their distended walls. When traumatized, these 
vessels may leak blood into the cyst, causing it to expand rapidly, provoking 
frightening pain. If bleeding continues, then the cyst may rupture into the 
collecting system, causing gross hematuria. Alternatively, it may rupture into 
the subcapsular compartment and eventually dissect through the renal 
capsule to fill the retroperitoneal space. In massive bleeding, the blood may 
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reach the skin that covers the flank and abdomen, where it is recognized as 
subcutaneous ecchymoses (Gray –Turner sign). 
Evidence from computed tomography scans indicates that intracyst 
hemorrhage, manifested as “hyperdense” subcapsular cysts, occurs in >90% 
of those with ADPKD 44. Often , dozens of superficial cysts bear the marks 
of intracyst bleeding. Direct inspection of the “hyperdense” cysts has 
revealed them to be filled with cellular debris derived from the breakdown of 
blood products.  
Patients with a history of renal hemorrhage evidenced by repeated 
episodes of gross hematuria have the largest kidneys8,32  and progress to renal 
insufficiency faster than those without this history. In a retrospective clinical 
study, Gabow et al.8,32 found that male athletes who had ADPKD and 
participated in constant sports had more hematuric episodes and developed 
renal insufficiency sooner than those who did not participate. In summary, 
renal hemorrhage caused by cysts occurs at any age and diminishes the 
quality of life. Hemorrhage is associated with larger kidneys and accelerated 
loss of renal function.  
Pain  
Pain is the most frequent symptom (-60%) reported by adult 
patients.45, 46 Acute pain may be associated with renal hemorrhage, passage 
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of stones, and urinary tract infections. Some patients develop chronic flank 
pain without identifiable etiology other than the cysts.  
Vascular endothelial growth factor (VEGF) produced by the cystic 
epithelium47 may promote angiogenesis, hemorrhage into cysts, and gross 
haematuria. Symptomatic episodes likely underestimate the frequency of 
cyst hemorrhage because more than 90% of ADPKD patients have 
hyperdense (CT) of high-signal (MRI) cysts reflecting blood or high protein 
content. Most Hemorrhages resolve within 2 to 7 days. If symptoms last 
longer than 1 week or if the initial episode occurs after the age of 50 years, 
investigation to exclude neoplasm should be undertaken. 
Approximately 20% of ADPKD patients have kidney stones usually 
composed of uric acid and calcium oxalate48,49. Metabolic factors include 
decreased ammonia excretion, low urinary pH, and low urinary citrate 
concentration. Urinary stasis secondary to the distorted renal anatomy may 
also play a role. A CT of the abdomen before and following contrast 
enhancement is the best imaging technique to detect small uric acid stones 
that may be very faint on plain films with tomograms and to differentiate 
stones from cyst wall and parenchymal calcifications. Stones may be missed 
if only a contrast-enhanced CT is obtained. 
As in the general population, urinary tract infections affect women 
more frequently than men. Most are caused by entero bacteriaceae50. CT and 
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MRI are useful to detect complicated cysts and provide anatomic definition, 
but the findings are not specific for infection. Nuclear imaging (67Ga or111 In-
labeled leukocyte scans) may be helpful, but false-negative and false-
positive results are possible. Cyst aspiration should be considered when the 
clinical setting and imaging are suggestive and blood and urine cultures are 
negative.  
Renal cell carcinoma (RCC) is a rare cause of pain in ADPKD. It does 
not occur more frequently than in the general population, but it may present 
at an earlier age with frequent constitutional symptoms and a higher 
proportion of sarcomatoid, bilateral, multicentric, and metastatic tumors51. A 
solid mass on ultrasound, speckled calcifications on CT and contrast 
enhancement, and tumor thrombus and regional lymphadenopathies on CT 
or MRI should raise the suspiction of carcinoma.  
Cosmetic deformation of the Abdomen. 
The Kidneys in some Patients enlarge to such an extent that belt and 
dress sizes must be increased substantially. The additional mass within the 
abdomen affects posture during standing and walking, which contribute to 
lower back pain that is separate from the renal pain. Although the effect of 
cosmetic abdominal distortion on lifestyle and quality of life has not been 
studied formally, nephrologists who treat large numbers of patients with 
ADPKD report that many of them find the enlarging abdomen highly 
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stressful. Huge kidneys may impair diaphragmatic motion enough to disturb 
sleep. Enlarged kidneys as result of cysts increase the risk that seat belts may 
cause injury52. Patients with greatly enlarged polycystic kidneys complain 
that seat belts increase pain in normal use. In summary, cosmetic 
deformation of the abdomen at any age is caused by renal cysts and can 
adversely affect the quality of life.  
Hypertension  
 Hypertension (BP>140/90) present in approximately 50% of 20 to 34 
yrs old patients  with ADPKD with normal renal function increases to nearly 
100% of patient with ESRD53 hypertension development is accompanied by 
reduction in renal blood flow, increased filtration fraction, abnormal renal 
handing of sodium extensive remodeling of the renal vasculature.  
 The association between renal size and prevalence of Hypertension  
supports the hypothesis that stretching  and compression of the vascular tree 
by cyst expansion causes ischiemia and activation of renin angiotensin 
system54. The expression of PCI and PC2 in vascular smooth muscle55,57 and 
endothelium58 along with enhanced vascular smooth muscle contractility59 
and impaired endothelial dependent vasorelaxation60 suggest that a primary 
disruption of polycystin function in the vasculature may also play a role in 
the early development of Hypertension and renal vascular remodeling. 
                                                                                                                                                
 19 
 
 There is strong evidences for local activation of the intrarenal renin 
angiotensin system. This include reduced Renal blood flow 61-64 shit of 
immunoreactive renin from juxtaglomerular apparatus to walls of arterioles 
and small arteries.65,66 Ectopic Synthesis of Renin67,68 ACE independent 
generation of Angiotensin II by a chymase like enzyme68 other factor 
proposed to contribute to HT in ADPKD include increased sympathetic 
nerve activity and plasma endothelin-1 level and insulin resistance69.  
 Hypertension has been associated with renal size in several studies of 
ADPKD6,10,42,70-79 and normal renal function, the number and volume of renal 
cysts determined with ultrasound were greatest in those with                     
hypertension70,73,80,82. In 165 adult patients with ADPKD, renal volumes 
determined with ultrasound were significantly greater in those with 
hypertension than in normotensive patients10. Similarly, in a recent cross – 
sectional study of 241 patients with ADPKD using magnetic resonance 
imaging (MRI) mean kidney volume was greater in the hypertensive patients 
than in the normotensive group21. Surgical removal of cysts in a large 
Chinese study of ADPKD patients improved BP control83,84 in summary, the 
development of hypertension is associated with the enlargement of ADPKD 
kidneys secondary to cysts. As explained in these early sections, expanding 
renal cysts and the vastly enlarged kidneys that the casus provoke serious 
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morbidities that damage the quality of life long before renal function is 
diminished. 
Renal insufficiency  
The development of renal insufficiency is highly variable in             
ADPKD9,36,39,41,85 renal failure has been reported in children86, and 
conversely individuals with the conditions may live a normal life expectancy 
without knowing that they have the disease. An early study estimated that 
approximately 70% of patients with ADPKD would develop renal 
insufficiency if they survived to age 6587. A 1984 report from Canada found 
that the probability of being alive and not having renal  function prognosis is 
judged. Individuals with mutations in PKD2 develop renal failure 
approximately 15 yr later than those with PKD1 mutations9,32,88-91. However, 
on clinical inspection , an individual with a PKD2 mutation does not seem 
physically different from someone with a PKD1 mutation.   
Extra renal Manifestations 
Polycystic liver disease  
Is the most common extrarenal manifestation it is associated with both 
PKDI and non PKD1 genotypes. PLD also occurs as a genetically distinct 
disease in the absence of renal cyst. Like ADPKD, ADPLD is genetically 
heterogeneous with two genes identified  (PRKCSH in chromosome 19 and 
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sec 63 in chromosome 6) accounting for approximately one third of isolated 
ADPLD cases 92-94 
 Prevalence of PLD in MRI in the CRISP study was 58%, 85%, and 
94% in 15-24 yrs old, 25-34 yr old and 35-46 yr old participant              
respectively72 hepatic cyst  are more prevalent, and hepatic cyst volume is 
larger in women than in men. Women who have multiple pregnancies or 
who have used and oral contraceptive  agent or estrogen replacement therapy 
have more severe disease suggesting an estrogen effect on hepatic cyst 
growth54,95 
 Topically PLD is asymptomatic but symptom result from mass effect, 
infection, hemorrhage mass effect include hepatic venous outflow 
obstruction, inferior vena cava compression portal vein compression or bile 
duct compression present on obstructive jaundice.96 
Cyst in other organs: 
 Cyst are found in pancreas in approximately 5%, arachinoid in 
approximately 8%, seminal vesicle in approximately 40%97-102 seminal 
vesicle cyst rarely result in infertility103, Defective sperm motility is another 
cause of infertility in ADPKD104, pancreas cyst are almost asymptomatic 
arachinoid membrane cyst are asymptomatice but may increase the risk of 
subdural haematoma.105, spinal meningeal diverticula may occur with 
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increased frequency and rarely present with intracranial hypotension due to 
cerebrospinal fluid leak106, ovarian cyst are not associated with ADPKD. 
   Vascular manifestations: 
 These in clude ICA and dolichoectasis, thoracic aortic and 
cervicocephalic artery dissection and coronary artery aneurysm they are 
caused by alteration in the vasculature directly linked to mutation in PKD1, 
or PKD2. PC1, PC2, are expressed in vascular smooth muscle cell 
intracerebral artery aneurysm occur in approximately by 6% of patient with 
negative family history and 16% of those with positive family History of 
aneurysm107, Rupture carries 35 to 50% risk of combined morbidity and 
mortality.108, 
Cardiac manifestations  
Mitral valve prolopse observed by echocardiogram is the most 
common valvular abnormality found in 25% of patients109,110 aortic 
insuffiency may occur in Association with dilation of the aortic root111.   
 
Diverticular disease:  
Colonic diverticulosis and diverticulitis are more common in ESRD. 
Patients with ADPKD than in those with other renal disease. Whether this 
increased risk extend to patient before the onset of ESRD is uncertain112. 
There have been reports of extra colonic diverticular disease113. 
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MATERIALS AND METHODS 
The present study titled “study of Autosomal Dominant polycystic 
kidney disease - clinical profile and family screening” was carried out in the 
department of General and Nephrology Department, Kilpauk Medical 
College Hospital Chennai – 10. 
Study Design  
• Descriptive study  
• Family screening study   
Period of study: 
 January 2010 to October 2010 
 Study Sample.  
• 30 Index cases  
Materials  
• Questionnaires 
• Blood pressure  
• Complete blood count  
• Urine Routine examination  
• Urine Culture and sensitivity  
• Urine Spot PCR  
• Random Blood sugar  
• Blood urea 
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• Serum Creatinine 
• Serum Calcium  
• Serum phosphate  
• Serum uric acid  
• ECG 
• Chest X –ray (PA  View) 
• Echo cardiogram  
• Ultrasonography  
• CT (Computed  tomography)   
Study Group  
The study group included persons with ADPKD and newly detected 
ADPKD patient by family screening method attending General Medicine 
and Nephrology Out patient / In patient was included in this study. 
Inclusion Criteria      
1. Known ADPKD patients (index case) and newly detected ADPKD 
(Screened case) patients who gave informed consent to participate in 
the study.  
2. ADPKD with CKD all stages. 
Exclusion Criteria  
• Patient unwilling for study.  
• Age below 14 yr not included in the study.  
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(Paediatrics age group patient not included, and under the age of 14% 
ultrasound is only correct in 50%)    
All the patient in the study group were selected without any bias for 
sex, Age group, above 14 yrs. With all the stages of CKD was included. A 
through history was recorded with particular emphasis on symptom of 
ADPKD. The presence of extra renal symptom was also included family 
screening was done by enquire about renal symptom, doing ultrasound 
examination and for doubtful case CT abdomen was done.  
A through General and systemic examination was carried. Echo 
cardiogram was done to rule out mitral valve prolapse, Aortic Regurgitation. 
CT abdomen also done to rule out pancreatic cyst, fallopian tube cyst, 
splenic cyst, and ovarian cyst.  
The diagnosis of ADPKD was confirmed when the presence of 
bilateral renal cysts, totaling 5 or more, were visualized by ultrasonography 
or computed  tomography, with positive family history or extra renal mani 
festatiosn such as hepatic cysts, aneurysms of cerebral arteries, and cysts of 
the pancreases (welling and Grantham, 1991). All patients  past and family 
histories were reevaluated and charts and ultrasonography report were 
reviewed retrospectively.  
Patients age at initial diagnosis, sex, past and family histories, 
symptoms and signs, laboratory data, electrocardiogram, abdominal or other 
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organ ultrasonography, computed tomography (CT), echocardiography, and 
other study data brain CT scan were analyzed. 
Blood sugar  
 It is estimated by glucose oxidase peroxidase method 
  Fasting glucose   ≥ 126 mgs/dl 
Random Blood Sugar  ≥ 200 mgs/ dl  
patients with symptom  
were taken as diabetes mellitus,  
 FPG = 100 – 125mgs/dl  considered as IGT (impaired glucose 
tolerance).  
Renal Function Test 
Blood urea 
Blood urea in this study was estimated by using DAM method 
(Diacetyl Monoxime) The normal value of which being 20-40 mgs /dl 
Serum creatinine 
 Serum creatinine was estimated by using modified Jaffe reaction 
method, alkaline pictrate method. The value of >1.5 mg in male and female 
and suggestive of renal impairment.  
Serum Electrolytes  
 Serum sodium and potassium were estimated by using flame 
photometer method.    
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Urine Analysis   
 Urine sample is collected for urine routine analysis which include 
sugar, protein , cytology and urinary sediments.  
Urine sugar is estimated by strip method, and Benizidine test   
Urine Albumin is estimated by heat coagulation method  
Urine Deposit - By direct microscopy examination.  
Urine spot PCR:  
 Urine sample is collected to estimate protein creatinine ratio. 
Sulfosalicylic precipitaton method, used for protein and creatinine 
estimation, latex turdity method also used.   
Complete blood count 
Total count, Differtential count done  by smear method to rule out 
infection  in UTI,  
Hb - shallish method, to rule out anemia in CKD 
ESR – Wintrobe method 
Urine culture and sensitivity 
 It was done by using plate method to rule out organism and 
sensitivity.  
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 Serum calcium, uric acid, Phosphate   
Serum calcium was done by flame photometer method Serum uric 
acid was done by Uricase POD method, Serum phosphate was done by UV 
end point  method to assess the CKD  stage.  
Creatinine clearance (Clcr) 
 If the serum creatinine is stable, the Glomemlar  Filtration Rate (GFR) 
can be estimated by using Cockcroft Gault formula  
Clcr m1/mt  = 
 
140- age x IBW in kg 
72 x Serum Creatinine (mg/dl) 
 
X0.85 for women  
 Glomemlar  Filtration Rate used to asses chronic kidney disease (CKD)  
stages   
CKD (Chronic Kidney Disease) stage  
NKF Definition of Chronic Kidney Disease 
• Kidney damage for three or more months, as defined by structural or 
functional abnormalities of the kidney, with or without decreased 
GFR, manifested by pathologic abnormalities or markers of kidney 
damage, including abnormalities in the composition of the blood or 
urine or abnormalities in imaging tests 
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• GFR <60 mL per minute per 1.73 m2 for three months or more, with 
or without kidney damage 
• As per definition ADPKD consider as CKD  
Stage GFR ml/mt /1.73 m2 
O 90a 
1 ≥ 90b 
2 60-89 
3 30-59 
4 15-29 
5 <15 
 
a- With risk factor  
b- With demonstrated kidney damage (e.g persistent proterinuria, 
abnormal urine sediment, and abnormal urine / blood biochemistry 
abnormal imaging studies.  
(Sources modified from National Kidney foundation, K/DOQI 
Clinical practice guideline for chronic kidney Disease evaluation, 
classification, stratification Am J Kidney Dis 39 Supp, 2002) 
Ultrasonography    
 The cyst in the kidney (uni / bilateral / multiple ) and cyst in other 
organ like spleen,  ovary, seminal vesicle, uterine tube were visualised by 
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using a Larsen turbo ltd, sonata pus Ultrasonogram in GKMCH Department 
of radiology. 
By Ultrasonography cysts are round or oval, echo lucent, thin walled, 
clearly delineated structures with smooth contours exhibiting sharply 
demarcated posterior walls and sound wave amplification behind the cysts as 
well as lateral extinction of the sound wave (lateral shadowing).  if cysts are 
solitary or infrequent, they  must be distinguished from haematoma or 
abscess, occasionally also from malignancy,  particularly lymphoma. 
The sensitivity of Ultrasonography to detect renal cysts in carrier of 
the ADPKD trait depends first on the quality of the Ultrasonography 
machine (with outdated machines assessments may not be reliable ) and 
second on the age of the porosities. as a rule of thumb, in individuals aged 30 
years, cysts are demonstrable by ultrasound in approximately 68% and above 
30 years , of age in approximately 89% of carriers of the genetic trait75 
Computed  Tomography  
Computed  tomography (CT) scanning  is a  sensitive as Ultrasound in 
the detection of cystic disease, although problems may arise with smaller 
cysts. CT scanning appears to be more specific than Sonography in 
differentiating an obstructed renal pelvis from a Parapelvic cyst. It also 
seems to be superior to Ultrasonographic images in helping assess 
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retroperitoneal rupture of a cyst and Perinephric extension of blood or pus 
from an infected cyst.62  
Stages of Hypertension (According To  Jnc Vii)  
Stages Systolic BP Diastolic BP 
Normal Less than 120 Less than 80 
Pre-hypertension   120 - 139 systolic    80 - 89 diastolic   
Stage 1 140 - 159 systolic  90 - 99 diastolic 
Stage 2 160 - 179 systolic 100 - 109 diastolic   
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RESULTS AND ANALYSIS 
The present study titled a study of “Autosomal dominant polycystic 
kidney disease - clinical profile and family screening” was undertaken in the 
Department of General Medicine and Nephrology, Kilpauk medical college 
hospital Chennai- 10. over the period of 10 months from January 2010 to 
October 2010. 
The study sample included 30 ADPKD patient (index case) attending 
as  outpatient / inpatient   in Dept of General Medicine  and Nephrology and 
15 cases detected from while doing family screening for that Index case. 20 
families were screened out of 30 families. In this 20 families 11 families 
were positive, 9 families were negative. In this 11 families 15 cases  were 
detected, from 75 screened person. 
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RESULTS 
1. In this study, age of patients attending OP/ IP is ranged from 27-67 yrs  
in index cases, 13-42 yr in screened cases (Table 1) 
2. The Maximum Numbers  of age group patients attending  OP/IP   in 
the age of 51-60 years. (Table 1) 
3. Male to female ratio was 15:15 in Index case, 4:11 in Screened case. 
(Table 2).  
4. In this study 19 patients presented with pain abdomen, 10 patients had   
UTI, 3 patients had haematuria, Renal calculus, 4 patients had 
Uraemic symptom, 5 patients had palpable mass. (Table 3)  
5. ADPKD was diagnosed by (a) Renal symptom like pain abdomen, 
palpable mass, gross haematuria, symptoms of UTI – 19 patients 
(63.4%). (b) by Incidental finding – 7 patients (23.7%) (c) by Uraemic 
symptoms  4 patients (13.3%)  (Table 4) 
6. Hypertension was found in 21 patients (70%) in Index cases, 1 patient 
in Screened case (6.6%). In 9 patients serum creatinine was <1.2 
mg/dl. This 9 patients had HT. In 21 patients serum creatinine was 
≥1.2 mg/dl. In the 21 patients 12 patients had HT (Table 6)  
7. All  the subject undergone abdominal ultrasonography more than once 
7 patient had  Undergone abdominal computed  tomography. 
Extrarenal mani festation was found to be in 11 patients out of 30 
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patients out of 30 patients in index cases, 5 patients out of 15 patients 
in screened cases   (table 7)  and their frequencies are shown (table 8) 
gastro intestinal manifestation include hepatic cyst in 4 cases (13.3%), 
pancreatic cyst 1 case (3.3%). 15 female patient out of 30 patient 
undergone pelvic Ultrasonogrphy, ovarian cyst found to be in 2 
patients (13.3%)  and uterine cyst found to be in 1patient (6.6%). 
Seminal vesicle cyst found in 1 patient (6.6%). All patient undergone 
echocardiogram done as a routine exam. Clinically three patient had 
mid systolic click, in this 2 patient found to be MVP (mitral valve 
prolapse) in echocardiogram. 4 patients c/o chronic headache for that 
patient undergone ct brain (plain) nothing abnormality detected. MRI 
A, MRI V is the ideal investigation for this case, because of 
affordability MRI A, MRI V not done.  
8. Anaemia was found to be in 9 patients in Index cases and 2 patients in 
Screened cases. Oedema was found to be in 2 patients in Index cases 
(Table 12) 
9. Mean age at first diagnosis was 40.5 ±18.2 (Mean ±SD) years, in 
Index case and in 15 cases (50%) first diagnosis of ADPKD has been 
made in patient 40’s and 50’s. 
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10. 5 patients presented with CKD  stage I,  9 patients presented with 
CKD stage II, 7  patients presented with CKD stage III and IV, 2 
patients presented with CKD stage V (Table 8) in Index cases.  
11. 21 patients on regular follow up in Index cases, 4 patients on regular 
follow up in Screened cases show in (Table 12). Urine spot PCR was 
raised in 6 (20%) patients in Index cases. 
12. In this study 20 families (out of 30 families) attended screening shown 
in (Table 13). In this 20 families, 11 families were found to be 
positive, 9 families were negative (Table 14)  
13. Urine spot PCR was increased in 6 patients (20%) in Index cases. 
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Table - 1  
DISTRIBUTION OF CASES BY AGE 
 
The mean age of distribution of case is this  
Study was 50.03 ±11.4 (Mean ± SD), 27-67 (Range) in Index Case. 
(28.2 ± 8.5) (Mean ± SD), 13- 42 (Range) in Screened case. 
 
 
 
 
 
S.No 
Age 
Group 
No of Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage 
1 <10 0 0 0 0 
2 11-20 0 - 5/15 33.3% 
3 21-30 2/30 6.7% 6/15 40% 
4 31-40 4/30 13.3% 4/15 26.7% 
5 41-50 8/30 26.6% 0 0 
6 51-60 13/30 43% 0 0 
7 61-70 3/30 10 0 0 
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Table - 2   
DISTRIBUTION OF CASES BY SEX 
 
S.No Gender 
No of Index 
cases 
Percentage
No of 
Screened 
cases 
Percentage 
1 Male 15/30 50 4/15 26.7% 
2 Female 15/30 50 11/15 73.3% 
 
Male and female was equal distribution in Index cases 15:15 (M:F) 
where as in Screened cases it was 4:11 (M.F). Most of the cases were female 
in screened cases.  
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 Table - 3 
DISTRIBUTION CASES BY CLINICAL PRESENTATION 
 
S.No 
Clinical 
Presentation 
No of 
Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage 
1 Pain abdomen 14/30 46.6% 2/15 13.3% 
2 UTI 10/30 33.3% 2/15 13.35 
3 Haematuria 3/30 10% - - 
4 
Uraemic 
Symptoms 
4/30 13.3% - - 
5 Palpable mass 5/30 16.6% - - 
 
Most of the cases had Pain abdomen in Index cases (14/30) UTI is the 
next most clinical presentation, 9 patients had UTI. In this 9 patient, 6 
patients urine culture and sensitirity found to be positive. In this 6 patients, 5 
patients urine shows E. coli growth. 1 patient urine shows klessiella growth.  
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Table - 4  
DISTRIBUTION OF CASES BY ROUTE OF DIAGNOSIS  
(INDEX CASES) 
 
S. No Route of diagnosis No of Cases Percentage
1 Renal symptoms 19/30 63.4% 
2 Uraemic symptoms 4/30 13.3% 
3 Incidental  Finding (Routine 
Checkup, Master Health 
Checkup, Infertility Checkup, 
Antenatal Checkup, Post 
Menopausal Checkup)  
7/30 23.3% 
 
Most of the cases were diagnosed by Renal symptom like Pain  
abdomen, palpable mass, haematuria, symptom of Renal Infection, stone and 
nocturia of about 19 patients (63.4%), By uraemic symptom 4 patients  
(13.3). By incidental finding like Routine check up. Master health checkup. 
Infertility checkup, antenatal checkup,post menopausal checkup 7 patients 
(23.3%). 
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Table - 5 
DISTRIBUTION OF CASES BY BLOOD PRESSURE 
 
S. No 
Blood 
Pressure 
No of 
Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage
1 Hypertension 21/30 70% 1/15 6.6% 
2 Non 
Hypertension 
9/30 30% 14/15 93.4 
 
Hypertension was found to be in 21(70%) patient in Index cases, 1 
patient in screened cases. In this 21 patients 9 patients were male, 12 
patient were female. 
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Table - 6  
DISTRIBUTION OF CASES BY HYPERTENSION VERSUS 
SERUM CREATININE  
 
S. No     Hypertension 
Serum Creatinine 
<1.2 mg /dl 
%  Hypertension 
Serum  Creatinine 
≥ 1.2  mg/dl 
%  
1 9/9 100% 12/21 57.14%
 
Serum creetinine was <1.2 mg/dl in 9 patients, this 9 patients had 
hypertension, where as in 21 patients serum creatinne was ≥ 1.2 gm/dl. 
In this 21 patients 12 patients had hypertension   
 
 
 
 
 
 
 
 
 
 47 
 
Table - 7  
DISTRIBUTION OF CASES BY EXTRA RENAL, RENAL 
MANIFESTATION  
 
S. 
No 
Extra Renal, 
Renal 
Manifestation 
No of 
Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage 
1 Extra renal 
manifestation 
11/30 36.7% 5/15 33.3% 
2 No extrarenal 
manifestation  
19/30 63.3% 10/15 66.7% 
 
 
Extra renal manifestation was found to be in 11 patients (36.7%) in index 
cases, where as in screened cases it was found to be 4 patients (33.3%). 
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Table - 8  
Distribution of cases by Extra renal manifestation 
 
S. 
No 
Extra renal 
Manifestation 
No of 
Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage 
1 Liver cyst  4/30 13.3 2/15 13.3 
2 Pancreatic cyst  1/30 3.3 -  
3 Ovarian cyst   2/15 13.3 1/11 9.1 
4 Uterine cyst  1/15 6.6 1/11 9.1 
5 Seminal vesicle 
cyst   
1/15 6.6 -  
6 Mitral valve 
prolapse (MVP) 
2/30 6.7 1/15 6.6 
 
In Index cases Liver cyst was found to be in 4 patients (13.3%), 
pancreatic cyst in 1 patient (3.3%), ovarian cysts in 2 patient ( 2/15) 
(13.3%) uterine cyst in 1 patient  (6.6%) MVP  in 2 patients 6.6%) where 
as in screened cases liver cyst in 2 patients (13.3%) ovarian cyst in 1 
patient (1/11) (9.1%) uterine cyst in 1 patient 1/11 (9.1%). MVP in 1 
patient.(6.6%). 
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Table - 9  
DISTRIBUTION OF CASES BY ANAEMIA/ OEDEMA   
 
S. No 
Anaemia, 
oedema 
distribution 
No of 
Index 
cases 
Percentage
No of 
Screened 
cases 
Percentage
1 Anaemia  9/30 30% 2/15 13.3% 
2 Oedema  3/30 10% - - 
 
Anaemia was found to be in 9 patients (9/30) 30%  Oedema was found to 
be in 3 patients (3/30) 10% in Index cases, where as in screened cases 
anaemia was found to be 2 patients 2/15 (13.3%). 
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Table - 10  
DISTRIBUTION OF CASES BY AGE AT FIRST DIAGNOSIS  
 
S. No Age  group 
No of 
Index 
cases 
Percentage
No of 
Screened 
cases 
Percentage
1 <10 0 0 0 0 
2 11-20 0 0 5/15 33.3 
3 21-30 4/30 13.3 6/15 40 
4 31-40 5/30 16.6 4/15 26.7 
5 51-60 9/30 30.7 0 0 
6 61-70 2/30 6.7 0 0 
 
The mean age at first diagnosis in this study was 40.9 ± 18.2 (Mean 
±SD) Range (24-65) in Index cases, where as in screened it was 24.9 
±7.9 (mean ±SD) Range (13-27). 
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Table - 11   
DISTRIBUTION OF CASES BY CKD STAGES BASED ON                     
COCK CROFT GAULT FORMULA 
 
S. No Stages 
No of 
Index 
cases 
Percentage 
No of 
Screened 
cases 
Percentage 
1 Stage I 5/30 16.6 15/15 100 
2 Stage II 9/30 30 0 0 
3 Stage III 7/30 23.3 0 0 
4 Stage IV 7/30 23.3 0 0 
5 Stage V 2/30 6.7 0 0 
 
In this study most of the case found to be CKD stage II, III, IV in Index 
cases. where as in screened cases all cases found to be CKD stage I. 
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Table - 12   
DISTRIBUTION OF CASES BY TREATMENT OF 
REGULARITY  
 
S. No 
Treatment 
of 
regularity 
No of 
Index 
cases 
Percentage
No of 
Screened 
case 
Percentage
1 Regular  21/30 70% 4/15 26.7 
2 Irregular  9/30 30% 11/15 73.3 
 
In this study 21 cases on regular follow–up. 9 case not on regular follow 
up in Index cases, where as in screened cases 4 cases on regular follow –
up 11 cases not on regular follow up. 
 
 
 
 
 
 
 
 
 57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 58 
 
Table - 13   
DISTRIBUTION OF CASES BY FAMILY SCREENING    
 
S. No 
Family screening 
details 
No of Index 
cases 
Percentage 
1 No. of family 
attended screening 
20/30 66.6 
2 No. of family not 
attended screening 
10/30 33.4 
 
In this study 20 families (66.6%) attended screening, 10 families (33.4%) 
not attended screening. This is because of social stigma about Renal 
disease and  lack of awareness about treatment modalities.   
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Table - 14   
DISTRIBUTION OF CASES BY FAMILY SCREENING 
RESULTS  
 
S. No 
Family screening 
results 
No of Index 
cases 
Percentage 
1 No. of Positive 
Family  
11/20 55 
2 No. of. Negative  
family  
9/20 45 
 
In this study 20 families attended screening. In this 20 families 11 (55%) 
families were found to the positive. 9  families (45%) were negative.   
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DISCUSSION 
ADPKD is the most common inherited renal disease (Gasow, PA. 
Bennet WM, Breuning MH, Peter DJM).ADPKD affect  approximately 
500000 population in the united states and is the more frequent genetic 
cause of renal failure in adult accounting for 10% patient on dialysis in 
U.S (Torra 2008). The prevalence was1:500 – 1:1000(5). 
As in any Autosomal Dominant disease, a patient with ADPKD has 
the defective gene on one of a pair of Autosomal chromosomes. 
Therefore, each offspring of an affected individual has a 50% chance of 
inheriting the chromosome carrying the defective gene and thus, 
inheriting the disease, ADPKD, which appeared clinically to be 1 entity 
of disease, actually results from at least 2 different gene defects. The 
most common gene, PKD1, is located on the short arm of chromosome 
No.16. This discovery has made it possible for new methods to diagnose 
the disorder in gene carriers prior to the development of renal cysts. The 
location of the other gene, which has been called PKD2 or non- PKD1, is 
chromosome No. 4. The location of third gene (PKD 3) has not yet been 
determined.  It appears that PKD1 accounts for approximately 90 percent 
of all ADPKD in the white population.72 The disease arise from a 
spontaneous mutation114. The pathogenesis, of ADPKD is due to The 
Altered epithelial cell growth, secretion, and extracellular matrix 
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production have all been shown to contribute to the development of 
ADPKD150. These abnormalities could, in fact, contribute to cyst 
development and extrarenal manifestations.  
Commonest age group of patients  attending Nephrology and General 
Medicine OP/IP Dept were 51- 60 yrs age group of about (13 cases) 43% 
41-50yrs age group were  8 cases (26.6%), 61-70 yrs age group were 3 
cases, 21-30 yrs age group were 2 cases, 31-40 Yrs age group were 4 
cases. The average age group of patient Attending OP/IP was 50.03 ± 
11.4 (Mean ± SD).  
That patients initial diagnosis were confirmed by 41-50 age group 
around 10 patients, 51-60 yrs age group around 9 patients, 61-70 yrs age 
group around 2 patients, 21-30yrs age group around 4 patients 31-40 yrs 
age group aground 5 patients.The average age at initial diagnosis in the 
study was 40.6 ± 18.8 (Mean ± SD) Range (24-65)  
The average Age at initial diagnosis in the study was  
40.6 ± 18.8 (Mean ± SD) Range 24-65 
Dr. S.K HK et al 39.2 ± 13.8118 
Dr. Alkis M. Pierides et al 1999 37.9 (Range 6-66 yrs ) 119 
ADPKD may be revealed by renal symptoms. However, in a 
substantial number of cases, the disease is asymptomatic and is 
discovered during routine clinical examination, on abdominal 
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ultrasonography performed for extrarenal reasons, or during genetic 
investigation.  
• Disease diagnosed by renal symptom 
 In this study   19/30 (63%)  
Dr. S.K.Ha et al   15/30 (50%)118. 
• Disease diagnosed by Incidental finding  
    In this study   7/30 (23.3%)  
Dr. S.K.Ha et al   8/30 (26.6%)118 
• Disease diagnosed by uremic symptom   
In this study  4/30 (13.3%) 
Dr. S.K.Ha et al   2/30 (6.7%)118. 
          Renal symptoms usually begin in the third or fourth decades. Common 
renal symptoms include flank or abdominal pain, palpable mass, haematuria, 
symptoms of renal infection and stones, and notcuria. Pain abdomen was 
reported in this study was 14/30 (46.6%) pain abdomen is the most frequent 
symptom reported by adult 45,46 Acute pain may be due to rend hemorrhage 
passage of stone , UTI,  3 patients presented with Renal calculus in this study 
this same 3 patients also presented with haematura, 9 patients presented with 
UTI, In this 9 patients, 6  patients  were confirmed by positive urine culture 
and sensitivity. (In 5 Patients Urine E. coli grown 1 patient Klebsielle 
grown)  
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Renal calculus   
In this study   3/30  (10%)  
Dr. Alkis M. Pierides et al 1999,    4/105 (3.8%)119  
Haematuria   
In this study    3/30 (10%)  
Dr. Alkis M. Pierides et al 1999   (12/105) (11.3%)119  
UTI  
In this study      9/30 (30%)  
Dr. Alkis M. Pierides et al 1999  24/105 (22.6%)119  
Uraemic symptoms  
In is this study     4/30 (13.3%)   
Dr. S.H.Ka et al     2/30 (6.7%)118  
 Hypertension is the most common cardiovascular manifestation, 
which occurs in about 70% of patients before the onset of renal 
insufficiency115 Hypertension appears to be related to the renin- 
angiotensin system116,117. The rennin- angiotensin system is stimulated 
significantly more in hypertensive patients with ADPKD than in 
comparable patients with essential hypertension. The increased rennin 
release, perhaps due to renal ischemia cause by renal cyst expansion, 
contributes to the early development of hypertension in ADPKD.117 
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Hypertension 
In this study      21/30 (70%) 
Dr. S.H.Ka et al      22/30 (73.3%)118 
Dr. Alkis M. Pierides et al 1999  24/105 (22.6%)119 
 Creatinine versus Hypertension     
In this study  
9 patients creatinine was <1.2 mg had HT, and 21 patients had 
creatinine ≥  1.2 mg, In this 21 patients 12  patients had HT,  
Dr. S.H Ka et al118  
16 patients creatinine was <1.2 mgs, 9 patients had hyper tension 14 
patients creatinine was ≥1.2 mgs, 13 patients had hyper tension 
Clinically 5 cases found to be  palpable renal mass by ballotable 
method. Other causes for palpable kidney are Diabetes mellitus  early stage, 
amyloidosis multiple myeloma.  
Cyst infection  
3 cases (10%)  presented with cyst infection uncomplicated cysts  are 
echolucent. Complicated  cysts exhibit a’ complex pattern. This  pattern is 
seen in cases with cyst infection, cyst haemorrhage (with or without cyst 
repture) or cyst calcification (usually is a residue after haemorrhage, but the 
possibility of calcification pointing to renal cell carcinoma should be kept in 
mind. 
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In the patient with ADPKD who complains of renal pain with or 
without macrohaematuria, one has to think of the following complications 
like cyst rupture, cyst hemorrhage, rupture of a bleeding cyst or bleeding 
from calyceal varicose,  and rupture of the kidney (after blunt trauma). As 
soon as the patient has fever or signs of inflammation (e.g elevated CRP 
concentration), cyst infection should be suspected, which may require 
diagnostic puncture of a complicated cyst. Cyst infection is a medical 
emergency.  
Extra renal manifestation was compared with Dr. S.H. Ka et al  
Extra renal 
manifestation 
No.of 
patients 
in this 
study 
Percentage
No.of 
patients 
Dr. S.H.Ka 
et al118 
Percentage 
Liver cyst  4/30 13% 21/30 70% 
Pancreatic cyst  1/30 3.3% 5/30 16.7% 
Splenic cyst  - - 2/30 6.6% 
Diverticulosis  - - 1/30 3.3% 
Ovarian cyst  2/15 13.3 3/21 14.3 
Uterine cyst  1/15 6.7 3/21 14.3% 
Seminal vesicle 
cyst  
1/15 6.7% 1/19 11.1% 
Mitral valve 
prolapse 
2/30 6.6% 5/30 16.7% 
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Anaemia was reported in this  study was 9 patients (30%) oedema was 
reported in this study was 3 patients (10%). 
Urine spot PCR was increased in 6 patients (20%). Proteinuria often 
used as a surrogate marker of  disease activity in other kidney disorders, is 
usually <1 g/d. proteinuria, observed more frequently in those with large 
(mean combined renal volume 1190 ml) rather than small (578 ml) renal 
volumes, is also associated with a greater likelihood of a subsequent loss of 
renal function (9).  
In index cases 5 patients founded to be   CKD stage 1, 9 patients 
founded to be CKD stage 2, 7 patients founded to be   in CKD stage 3 and 4. 
2 patients founded to be   CKD stage 5, but in the screened cases all cases 
(15 cases) found to be CKD stage 1.  
The natural history of renal disease may occur as early as the first 
decade of life, or renal function may be well maintained into the eighth 
decade. Approximately 50% of patients had well preserved renal function at 
70 years of age  
Family Screening  
Family screening is the screening method to detect the new cases, 
since ADPKD is familial diseases as a 50% chance of inheriting the 
chromosome carrying the defective gene and dose inheriting diseases. When 
we screen the family early, we can detect the disease early and delay the 
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morbidity and mortality due to ADPKD, Family History may be positive in 
this study was 11 cases (55%)  out of 20  cases. 15(20%)  cases were 
detected from 75 screened cases.  
Positive Family History  
In this study 11/20 (55%)  
Dalgard 1957, Iglesias et al 1983  (60%) 119   
Dr. S.H Ka et al 6/30 (16.3%) 118 
Family screening was done in 20 patients out of 30 patients, from this 
20 patients family I screened around 75 person. 10 patients family not 
attending family screening study. This is because  of social stigma about the 
kidney diseases and lack of awareness about the disease. In this 20 families 
11 families were positive, 9 families were negative. In this 11 families 15 
cases were detected. In this 15 cases, 4 male and 11 female patients. Chances 
of female to female transmissions will be high, in this study because 9 
screened female patients coming from female index cases. Since 15 cases, 
detected from 75 person the positivity is every 5th person in the family.  
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SUMMARY 
Recently with the widespread use of new imaging techniques, the 
diagnosis of autosomal dominant  polycystic kidney disease (ADPKD) is 
increasing. To analyses the extrarenal manifestation of ADPKD in Kilpauk 
Medical College Hospital retrospectively patients was  studied the clinical 
characteristics of 30 patients with ADPKD. Thirty patients with ADPKD 
who had been diagnosed at Nephrology and General Medicini Department, 
Kilpauk Medical College Hospital. were recruited for this study. All patients 
past and family histories were re-evaluated, charts, ultrasound scan and CT 
scan were reviewed retrospectively. The male to female ratio was 15:15 in 
index cases, 4:11 in screened  cases and the age of initial diagnosis was 40.6 
± 18.2 (Mean ±SD) years. In 19 cases (50%), ADPKD had been diagnosed 
by renal symptoms; in 7 cases (26.7%), by incidental finding like routine 
checkup, AN checkup, Infertility checkup, Master Health Checkup,post 
menopausal chekup and in 4 cases by Uremic symptoms in Index cases.  
Extrarenal involvement included Liver cysts (13.3% in index cases), (13.3% 
in screened case) and pancreatic cysts (3.3%), Ovarian cyst 6.7% in index 
cases, 6.7% in screened cases, uterine cyst 3.3 % in index cases 6.6% in 
screened cases seminal vesicle cyst 3.3%, index cases, Mitral valve prolapse 
6.7% in index cases, 6.7% in screened cases Renal cysts are only   one of a 
myriad of renal and extrarenal  manifestation of ADPKD. ADPKD should be 
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managed systematically since this disorder is a systemic disease with 
clinically important involvement of the cardiovascular system, the 
gastrointestinal tract, the genitourinary system, and the musculoskeletal 
system. Family screening was done in 20 families out of 30 familes. In this 
20 families 11 families were positive, 9 families were Negative.  In this 11 
families 15 cases were detected. In this 15 cases 11 cases were children of 
patients. 4 cases were siblings of patients.  
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CONCLUSION 
• In ADPKD , most common clinical presentation  in 40’s and 50’s  age 
group in this study  
• ADPKD is higher in female the male in this study  
• Pain abdomen and symptoms of  UTI is the most common symptom  
• Hypertension  is the most common clinical presentation. ADPKD is 
known risk factors for renal failure, when it is associated with HT, it 
doubles the risk factors for renal failure.   
• Liver Cyst is the most common extrarenal manifestation  
• Mitral valve Prolapse is the most common  extrarenal cardiovascular 
abnormality  
• In this study 15 cases have been detected from 11 families.    
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STUDY LIMITATION 
• Study population was small  
• Family screening study was  not able to do for all index cases, 20 
cases were screened. For 10 case Screening could not be done .This is 
because of social stigma, and lack of awareness about the disease  
• MRI was not done in the study to Rule out  Berry aneurysm because 
of poor affordability  
• Colonoscopy was not done in the study because of patients did not 
give consent for colonoscopy  
• Follow up study was not done in this study.     
• In this study I did not get exact proportion of ADPKD patients with 
family association 
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RECOMMENDATION  
• In our country, genetic study is not possible, since USG in readily 
available and  relatively inexpensive . So routine ultrasound scan to be 
done in all Hypertension, UTT  symptom, and Pain abdomen   to rule 
out  ADPKD. 
• Family screening to be done is all ADPKD Patients to delay and 
prevent morbidity and mortality due to ADPKD  
• Follow up study to be done all ADPKD cases, to rule out  disease 
progression.  
• BP control, control of infection, Bed rest during Haematuria, 
Infection, pain abdomen, will delay progression of renal failure.   
 
 
 
 
 
 
 
 
 
 
 73 
 
BIBLIOGRAPHY 
1. Daous MC, Reynolds DM, Bichet DG, Somplo S. Evidence for a third 
genetic locus for autosomal dominant Polycystic kidney disease. 
Genomics 1995;25:733-736. 
2. De Almeida S, de Almeida E, Peters D et al. Autosomal dominant 
polycystic kidncy disease: evidence for the existence of  a third locus 
in a Portuguese family. Hum Genet 1995;96:83-88. 
3. Veldhuisen B, Saris J, de Haij S et al. A spectrum of mutations in the 
second gene for autosomal dominant polycystic kidney disease 
(PKD2).am J Hum Genet 1997; 61:547-555. 
4. Peral B, Gamble V, Strong C, et al Identification of mutations in the 
duplicated region of the polycystic kidney disease 1 (PKD1) gene by a 
novel approach. Am J H um Genet 1997; 60:1399-1410.  
5. Gabow PA: Definition and natural history of autosomal dominant 
polycystic kidney disease Jonhn waston ML Torre editor PKD Oxford 
University press 1996, pp 333-5 
6. Ong AC, Harris PC: Molecular pathogenesis of ADPKD: The 
polycystin complex gets complex. Kidney Int 67: 1234-1247, 2005 
7. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J 
Med 329: 332-342, 1993  
 74 
 
8. Gabow PA, Duley I, Johnson AM: Clinical profiles of gross hematuria 
in autosomal dominant polycystic kidney disease. AM J Kidney Dis 
20: 140-143, 1992 
9. Gabow PA, Champan AB Johnson AM, Kaehny WD, Kimberling WJ, 
Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of 
renal disease in autosomal-dominant polycystic kidney disease. 
Kidney Int 41: 1311-1319, 1992  
10. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, 
Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and 
hypertension in autosomal dominant polycystic kidney disease. 
Kidney Int 38: 1177-1180, 1990  
11. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease. 
Nefrologia 23 [Suppl 1]: 14-22, 2003 
12. Grantham JJ: The etiology, pathogenesis, and treatment of autosomal 
dominant polycystic kidney disease: Recent advances. Am J Kidney 
Dis 28: 788-803, 1996 
13. Chapman AB, Johnson AM, Gabow PA, Schrier RW: Overt 
proteinuria and microalbuminuria in autosomal dominant polycystic 
kidney disease. J Am Soc Nephrol 5: 1349-1354, 1994 [Abstract] 
 75 
 
14. Grantham JJ, Geiser JL, Evan AP:  Cyst formation and growth in 
autosomal dominant polycystic kidney disease. Kidney Int 31: 1145-
1152, 1987  
15. Grantham JJ: Polycystic kidney disease: Neoplasia in disguise. Am J 
Kidney Dis 15: 110-116, 1990  
16. Grantham J, Cowley BJ, Torres VE: Progression of autosomal 
dominant polycystic kidney disease (ADPKD) to renal failure. In: The 
Kidney: Physiology and Pathophysiology, Vol. 2, edited by Seldin D, 
Giebisch G, Philadelphia, Lippincott Williams & Wilkins, 2000, pp 
2513-2536 
17. Bello-Reuss E, Holubec K, Rajaraman S: Angiogenesis in autosomal-
dominant polycystic kidney disease. Kidney Int 60: 37-45, 2001  
18. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E: 
Renal histology in polycystic kidney disease with incipient and 
advanced renal failure. Kidney Int 42: 1259-1265, 1992 [Medline0 
19. Zheng D, Wolfe M, Cowley BD Jr, Wallace DP, Yamaguchi T, 
Grantham JJ: Urinary excretion of monocyte chemoattractant protein-
1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 
14: 2588-2595, 2003. 
20. Torres VE: Cyclic AMP, at the hub of the cystic cycle. Kidney Int 66: 
1283-1285, 2004. 
 76 
 
21. Torres VE: Hypertension, proteinuria, and progression of autosomal 
dominant polycystic kidney disease: Where do we go from here? Am J 
Kidney Dis 35: 547-550, 2000  
22. Ravine D, Gibson RN, Walker RG, Sheffield L, Dank OM, Kincaid 
SP. Evaluation of ultrasonographic diagnostic criteria for autosomal 
dominant polycystic kidney disease. Lancet 1994; 343: 824-7. 
23. Harris PC, Torres VE. Autosomal dominant polycystic kidney disease. 
Gene Rev [cited June 2006]. Available from: http: // 
www.genetests.org/servlet/access?id=8888891&key=chDzcmoQ73d4
2&gry=INSERTGRY&fcn=y&fw=u9Rf&filename=/glossary/profiles/
pkd-ad/details. html 
24. Brenner M, Rector C. Clinical criteria for diagnosis of autosomal 
dominant polycystic kidney disease. In: Brenner M, editor The 
Kidney, 6th edn. Philadelphia: W.B. Saunders & Co.; 2000: pp 1706-
30. 
25. Chapman AB, Guay-Woodford LM, Grantham JJ, et al: Renal 
structure in early autosomal dominant polycystic kidney disease 
(ADPKD); the Consortium for Radiologic Imaging Studies of 
Polycystic Kidney Disease (CRISP) Cohort. Kidney Int 64:1035-1045, 
2003 
 77 
 
26. Grantham JJ, Torres VE, Chapman AB, et al: Volume progression in 
polycystic kidney disease. N Engl J Med 354:2122-2130, 2006. 
27. Torres VE: Water for ADPKD? Probably, Yes. J Am Soc Nephrol 
17:2089-2091, 2006. 
28. Wong H, Vivian L, Weiler G, Filler G: Patients with autosomal 
dominant polycystic kidney disease hyperfiltrate early in their disease. 
Am J Kidney Dis 43:624-628, 2004. 
29. Torres VE, King BF, Chapman AB, et al: Magnetic resonance 
measurements of renal blood flow and disease progression in 
autosomal dominant polycystic kidney disease. CJASN 2:112-120, 
2006. 
30. Chapman AB, Johnson AM, Gabow PA: Pregnancy outcome and its 
relationship to progression of renal failure in autosomal dominant 
polycystic kidney disease. J Am Soc Nephrol 5:1178-1185, 1994. 
31. Duncan KA, Cuppage FE, Grantham JJ: Urinary lipid bodies in 
polycystic kidney disease. Am J Kidney Dis 5:49-53, 1985. 
32. John AM, Gabow PA: Idendification of patients with autosomal 
dominant polycystic kidney disease at higher risk for en-stage renal 
disease. J Am Soc Nephrol 8: 1560-1567, 1997 
 78 
 
33. Gabow PA, Ikle DW, Holmes JH: Polycystic kidney disease: 
Prospective analysis of nonazotemic patients and family members. 
Ann Intern Med 101: 238-247, 1984. 
34. Danovitch GM: Clinical features and pathophysiolocy of polycystic 
kidney disease I man. In: Cystic Diseases of the Kidney, edited by 
Gardner KD Jr, New York , John Wiley and Sons, 1976.p255. 
35. Dalgaard OZ: Bilateral polycystica disease of the kidneys. Acta Med 
Scand 328: 1-255, 1957 
36. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Bryant 
JI: Autosomal dominant polycystic kidney disease: Symptoms and 
clinical findings. Q J Med 53: 511-522, 1984. 
37. Rall JE, Odel HM: Congenital polycystic disease of the kidney: 
Review of the literature, and data on 207 cases. Am J Med Dis 218: 
399-407, 1949. 
38. Simon HB, Thompson GJ: Congenital polycystic disease. JAMA 159: 
657-662, 1955. 
39. Higgins CC: Bilateral polycystic kidney disease. Arch Surg 65: 318-
329, 1952. 
40. Braasch WF: Clinical data of polycystic kidney. Surg Gynecol Obstert 
23:697-702, 1916. 
 79 
 
41. Braasch WF, Schacht FW: Pathological and clinical data concerning 
polycystic kidney. Surg Gynecol Obstet 57: 467-475, 1933. 
42. Chapman AB: Cystic disease in women: Clinical characteristics and 
medical management. Adv Ren Replace Ther 10: 24-30, 2003. 
43. Levine E, Grantham JJ: Perinephric hemorrhage in autosomal 
dominant polycystic kidney disease: CT and MR findings. J Comput 
Assist Tomogr 11: 108-111, 1987. 
44. Levine E, Grantham JJ: High-density renal cysts in autosomal 
dominant polycystic kidney disease demonstrated by CT. Radiology 
154: 477-482, 1985. 
45. Bajwa ZH, Gupta S, Warfield CA, Steinman TI: Pain management in 
polycystic kidney disease. Kidney Int 60:1631-1644, 2001. 
46. Bajwa ZH, Sial KA, Malik AB, et al: Pain patterns in patients with 
polycystic kidney disease. Kidney Int 66:1561-1569, 2004. 
47. Bello-Reuss E, Holubec K, Rajaraman S: Angiogenesis in autosomal-
dominant polycystic kidney disease. Kidney Int 60:37-45, 2001. 
48. Torres VE, Ericson SB, Smith LH, et al: The association of 
nephrolithiasis and autosomal dominant polycystic kidney disease. 
Am J Kidney Dis 11:318-325, 1988. 
 80 
 
49. Torres VE, Wilson DM, Hattery RR, Sequra JW: Renal stone disease 
in autosomal dominant polycystic kidney disease. Am J Kidney Dis 
22:513-519, 1993. 
50. Elzinga LW, Bennett WM: Miscellaneous renal and systemic 
complications of autosomal dominant polycystic kidney disease 
including infection. In Watson ML, Torres VE (eds): Polycystic 
Kidney Disease. Oxford, Oxford Medical Publications, 1996, pp 483-
499. 
51. Keith D, Torres VE, King BF, et al: Renal cell carcinoma in 
autosomal dominant polycystic kidney disease (review). J Am Soc 
Nephrol 4:1661-1669,1994. 
52. Amend WJ: Polycystic kidney disease and seatbelts. Am Intern Med 
79: 287-92, 1973 [Abstract/Free Full Text] 
53. Kelleher CL, McFann KK, AM, schrier RW: characteristics of 
hypertension in young adults with autosomal dominant polycystic 
kidney disease compared with the general U.S. population. Am J 
hypertens 17:1029-1034, 2004. 
54. Gabow P, Johnson AM, Kaehny WD, et al: Risk factors for the 
development of hepatic cysts in autosomal dominant polycystic kidney 
disease. Hepatology 11:1033-1037, 1990. 
 81 
 
55. Griffin MD, Torres CE, Grande TP, Kumar R.Vascular Expression  of 
polycystin . J AM soc Nephrol 8:616-626, 1997 
56. Torres VE, Cai Y, Chen X, et al : Vascular expression of polycystin,  
2. J.Am soc Nephrol 12:1 9, 2001. 
57. Qian Q, Lim M, Cai Y, et al: Analysis of the polycystins in aortic 
smooth muscle cells. J Am Soc Nephrol 14:2280-2287, 2003. 
58. Ibraghimov – Beskrovnaya O, Dackowski WR, Foggensteiner L, et al: 
In vitro synthesis, in vivo tissue expression, and subcellular 
localization indentifies a large membrane associated protein. Proc Natl 
Acad Sci USA 94:6397-6402, 1997. 
59. Qian Q, Hunter LW. Du H, et al: Pkd2+/- vascular smooth muscels 
develop exaggerated vascontraction in response to phenylephrine 
stimulation. J AM Soc Nephrol 18, 485-493. 2006. 
60. Wang. D. Iversen J, Wilcox CS. Strandgaard S, et al: Endothelial 
dysfunction and reduced nitric oxide in resistance arteries in 
autosomal – dominant polycystic kidney disease. Kidney Int 64: 1381-
1388, 2003. 
61. Chapman AB, Johnson H, Gabow PA, shrieri RW: The renin 
angiotensin aldosterone system and autosomal dominant polycystic 
kidney disease. N Engl J Med 323:1091- 1096, 1990. 
 82 
 
62. Antiga L. Piccineelli M.Fasolini G, Ene – Iordache B, Ondei, Bruno s, 
et al. computed tomography evaluation of Autosomal dominant 
polycystic kidney progression a progress report Ch: J AM soc Nephrol 
Jul 2006 1(4) 754-60.   
63. Torres VE,Wilson DM, Burnettt JC Jr, et al: Effect to inhibition of 
converting enzyme on renal homodynamics and sodium management 
in polycystic kidney disease. Mayo clin proc 66:1010-1017, 1991. 
64. Waston M, Macnicol AM, Allan PL, Wright AF: Effects of 
angiotensin Converting enzyme inhibition in adult polycystic kidney 
disease. Kidney Int 41:206-2010.1992 
65. Graham P. Lindop G: The antomy of the renin –secreting cell in adult 
polycystic kidney disease. Kidney int 33:1084-1090, 1988. 
66. Torres V. Donovan KA, Scicli G, et al : Synthesis of renin by 
tubulocystic epithelium in autosomal dominant polycystic kidney 
disease. Kidney int 42:364-373, 1992. 
67. Loghman – Adham M. suto CE, inagami T, el al: The angiotensin II-
generating activity in end stage human autosomal dominant polycystic 
kidney disease. Am J physio renal physiol 287:F775 –F788, 2004. 
68. Mcpherson EA, Luo Z. Brown RA, et al : Chymase – like angiotensin 
II –generating activity in end stage human atuotsomal polycystic 
kidney disease. J Am soc Nephrol 15:493-500, 2004. 
 83 
 
69.  Klein IH, Lightenberg G, Oey PL, et al: Sympathetic activity is 
increased in polycystic kidney disease and is associated with 
hypertension. J Am Soc Nephrol  12:2427-2433,2001. 
70. Seeman T, Sikut M, Konrad M, Vondrichova H, Janda J, Scharer K: 
Blood pressure and renal function in atuosomal dominant polycysic 
kidney disease. Pediatr Nephrol 11:592-596, 1997  
71. Grantham JJ: Mechanims of progression in autosomal dominant 
polycysic kidney disease. Kidney Int suppl 63: S93-97, 1997. 
72. Bae KT ZhuF, Chapman AB et al, Magnetic Resonance imaging 
evaluation of hepatic cyst in early autosomal dominant polycystic 
kidney disease clin  J AM, Soc Nephrol 1 :64-69, 2006. 
73. Seeman T, Dusek J, Vondrichova H, Kyncl M, John U, Misselwitz J, 
Janda J: Ambulatory blood pressure correlates with renal volume and 
number of renal cysts in children with autosomal dominant polycystic 
kidney disease. Blood press Monit 8: 107-110, 2003. 
74. Fick – Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier 
RW:Relationship between renal volume growth and renal function in 
autosomal dominant polycystic kidney disease: A longitudinal study. 
Am J Kidney Dis 39: 1127-1134, 2002. 
 84 
 
75. Champan AB, Gabow PA Hereditary and congenital renal cystic 
disease. In: Massry & Glassock’s Textbook of Nephrology, Vol. 1, 3rd 
edn, William & Wilkins, Baltimore,1995; 913- 930 
76. Kiemberling WJ,  Kumar S, Gabow PA, Kenyon JB, Conolly L, 
Somlo S: Autosomal dominant polycystic kidney disease: localization 
of the second gene to chromosome 4q 13-q23. Genomics 18:467-472, 
1993. 
77. Schrier RW, Mc Fann KK, Johnson AM: Epidemiological study of 
kidney survival in autosomal dominant polycystic kidney disease. 
Kidney Int 63:678-685, 2003. 
78. Chapman AB, Schrier RW: Pathogenesis of hypertension inautosomal 
dominat polycystic kidney disease. Semin Nephrol 11:653-660, 1991. 
79. Thomsen HS, Madsen JK, Thaysen JH, Damgaard –Petersen 
K:Volume of polycystic kidneys during reduction of renal function. 
Urol Radiol 3: 85-89, 1981. 
80. Seeman T, Dusek J, Vondrak K, Blahova K, Simkova E,Kreisinger J, 
Dvorak P, Kyncl M, Hribal Z, janda  J: Renal Concentrating capacity 
is linked to blood pressure in children with autosomal dominant 
polycystic kidney disease. Physiol Res 53: 629-634, 2004. 
 85 
 
81. Ravine D, Walker RG, Gibson RN, Sheffield LJ, Kincaid Smith P, 
Danks DM: Treatable complication in undiagnosed cases of autosomal 
dominant polycystic kidney disease. Lancet 337: 127-129, 1991. 
82. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E:Elevated 
Blood pressure profile and left ventricular mass in children and young 
adults with autosomal dominate polycystic kidney disease.  J Am Soc 
Nephrol 3: 1451-1457, 1993. 
83. Ye M: (Etiology and pathogenesis of adult polycystic kidney disease). 
Zhonghua wai Ke Za Zhi 22: 44-48, 1984. 
84. Ye M, An SY, Jiang HM: (Clinical analysis of 141 case of adult 
polycystic kidney disease). Zhoghua Wai Ka Za Zhi 24: 73-76, 1986. 
85. Franz KA, Reubi FC : Rate of functional deterioration in polycystic 
kidney disease. Kidney Int 23: 526-529, 1983. 
86. Sedman A, Bell P, Manco-Johnson M, Schrier R, Warady BA,Heard 
EO, Butler – simon , N, Gabow P: Autosomal dominant polycystic 
kidney disease in childhood: A longitudinal study. Kidney Int  
31:1000-1005, 1987. 
87. Mitcheson H, Williams G, Castor JE: Clinical aspects of polycystic 
disease of the kidneys. BMJ 1: 1196-1199, 1977. 
 86 
 
88. Churchill DN, Bear JC, Morgan J, Payne RH, Mc Manamon PJ, Gault 
MH: Prognosis of adult onset polycystic kidney disease re-evaluated. 
Kidney Int 26: 190-193, 1984. 
89. Hateboer N, v Dijk  MK, Bogdanova N, Coto E, Saggar Malik AK, 
san Millan JL, Torra R, Breuning M, Ravine D: Comparison of 
phenotypes of polycystic kidney disease types 1 and 2. European 
PKD1 – PKD2 study Group. Lancet 353: 103-107, 1999. 
90. Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks 
E, Parfrey P, Torra R, San- millan JL, Coto E, Van dijk M, Breuning 
M, Peters D, Bogdonova N, Ligabus G, Albertazzi A, Hateboer N, 
Demetriou K, Pierides A, Deltas C, St George – Hyslop P, Ravine D,  
Pei Y: Genotype renal function correlation in type 2 autosomal 
dominant polycystic kidney disease. J Am Soc Nephrol 14: 1164-
1174, 2003. 
91. Torra R, Darnell A, Estivill X, Botey A, Revert L: Interfamilial and 
intrafamilial variability of clinical expression in ADPKD. Contrib 
Nephrol 115:97-101, 1995. 
92. Li A, Davila S, Furu L, et al: Mutations in PEKCSH cause isolated 
sutosomal dominant polycystic liver disease. Am J Hum Genet 
72;691- 703.2003. 
 87 
 
93.  Drenth JP, te Morsche RH, Smink R, et al Germine Mutations in  
PRKCSH are associated with autosomla dominant polycystic liver 
disease. Nat Genet 33:345-347, 2003. 
94. Davila S, Furu L. Gharavi, AG, et al: Mutations in SEC63cause 
autosomal dominat polycystic liver disease, Net Genet 36:575-577, 
2004. 
95. Shertha R, McKinely C, Russ P, et al: Postmenopausal estrogen 
theraphy selectively stimulates hepatic enlargement in women with 
autosomal dominant polycystic kidney disease. Hepatology 26:1282-
1286.1997. 
96. Torres V, Rastoqi S, King BF, et al: Hepatic venous outflow  
obstruction in autosomal dominant polycystic kidney disease. J Am 
Soc Nephrol 5:1186-1192. 1994. 
97. Danaci M, Akpolat T, Bastermir M, et al: High incidence of common 
bile  duct dilatation in autosomal dominant polycystic kidney disease 
patients.  Am kidney Dis 27:321-326, 1996. 
98. Alpern MB, Dorfman RE, Gross BH, et al: The prevalence of seminal 
vesicle cysts in autosomal dominant polycystic kidney disease 
Nephrol  Dial Transplan 13:2825 -2828, 1998. 
 88 
 
99. Wijdicks EF, Torres VE, Schievink WI: Chronic Subdural Hematoma 
in  autosomal dominant polycystic kidney disease. Am J Kidney Dis 
35:40- 43, 200. 
100. Schievink W, Huston J 3rd, Torres VE, et al: Intracranial cysts in 
 autosomal dominant polycystic kidney disease. J Neurosourg  
83:1004-1007, 1995. 
101. Alehan FK Gurakan B. Agidere M. Familial arachinoid cyst is 
association with ADPKD paediatrics  110 et -3 2000  
102. Nicolau C, Torra R, Bianchi L, et al: Abdominal sonographic study of  
atuosomal dominant polycystic kidney disease . J Clin Ultrasound 
28:277- 82, 2000. 
103. Li Vecchi M, Cianfrone P, Damiano R, et al: Infertility in adults with 
polycystic kidney disease. Nephrol Dial Transplant 18:190-191, 2003. 
104. Okada H, Fujioka H, Tatsumi N, et al: Assisted reproduction for 
infertile patients with 9+0 immotile spermatozoa associated with 
autosomal dominant polycystic kidney disease (published erratum 
appears in Hum  Report 14:1166, 1999). Hum report 14: 110-113, 
1999. 
105. Abderrahim E, Hedri H, Laabidi J, et al: Chronic subdural haematoma 
and autosomal polycystic kidney disease: report of two new cases. 
nephrology (Carlton ) 9:331-333 2004. 
 89 
 
106. Schievink W, Torres V: Spinal meningeal diverticula in autosomal 
 dominant polycystic kidney disease. Lancet 349:1223-1224, 1997. 
107. Pirson Y, Chauveau D, Torres VE: Management of cerebral 
aneurysms    in autosomal dominant polycystic Kidney disease: 
unruptured asymptomatic  intracranial aneurysms. J Am Soc Nephrol 
13:269-276, 2002. 
108. Inagawa T:Tredns in incidence and case fatality rates of aneurysmal 
 subarachnoid hemorrhage in Izumo city, japan, between 1980-1989  
and  1990-1998. Stroke 32:1499-1507, 2001.155.Hossack KF. 
109. Laddy CL, Johnson AM, et al :Echocardiographic findings in  
autosomal dominnat polycystic kidney disease, N Engl J Med 
319:907- 912. 1988. 
110. Lumiaho A,Ikaheimo R, Miettinen R, et al: Mitral Valve Prolapse and    
  mitral regurgitation are common in patients with polycystic kidney 
 disease type 1. AM J Kidney Dis38:1208-1216, 2001. 
111. Leier CV, Bakar PB, Kilman JW, et al: cardiovascular abnormalities  
associated with adult polycystic kidney disease. AM lntern Med 
100:683- 688, 1984. 
112. Sharp CK, Zeligman BE, Johnson AM, et al : Evaluation of colonic 
 diverticular disease in atuosomal dominat polycystic kidney disease 
 without end –stage renal disease. Am J Kidney Dis 34:863-868, 1999. 
 90 
 
113. Kumar S, Adeva M, King  BF, et al., Duodenal diverticulosis in 
autosomal dominant polycystic kidney disease. Nephrol dial 
Transplant 21:3576- 3598, 2005. 
114. Gabow PA Polycystic kidney disease chues to pathogenesis kidney Int 
40: 989-996. 1991. 
115. Bell PE, Hossack, KF, Gabow PA, Durr JA, Johnson  
116. Chapman AB, Johnson AM, Gabow PA, Schrier RW: The renin 
angiotensin – aldosterone system and ADPKD N. Engl J Med 
323:1091-1096, 1990. 
117. Dalgard OZ, Bilateral polycystic disease of the kidneys: a follow up of 
two hundred and eighty – four patients and their families. Acta Med 
Scand 158:326-329,1957 
118. Sung-Kyu Ha, Chong-Hoon Park, June-Sick Kna, Seung-Yong Lee, 
Jung-II Lee, Seung-Jung Kim, Jung-Kun Seo, Ho-Yung Lee, and Dae-
Suk Han Extrarenal Manifestations of Autosomal Dominant 
Polycystic Kidney Disease Yonsed Medical Journal Vol. 38, No. 2, 
pp. 111-116, 1997 
119. Alkis Pierides, Kyproulla Demetrioul, Cyrysa Tziakouri, Kristiana 
Anninou, Andri Eleftheriou, Michalis Koptides, Alexia Nicolaou, 
C.Constantinou Deltas Autosomal dominant polycystic kidney 
disease-type 2. Ultrasound, genetic and clinical correlations – 1311 – 
Nicosia, Cyprus.  
 
 91 
 
PROFORMA  
         Serial No. 
         OP  / IP No: 
Name of the patient  : 
Age     :     Sex:   M   F 
 : 
Address with phone No : 
 
 
Socio Economic Status  : Low   Middle        Higher  
Education status   : Below 12th Std         Graduate  
      Post- Graduate  
Occupation    : Self            Private  Govt.           
Cooly  
Income per month   : Below 2000           2001-5000                 
                                                   Above 5000 
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Urinary symptoms  : 
Duration   : 
 
 
Past History 
   
Duration  
   
Family History    
 
Personal History  
  
Duration   
Total Dose    
H/o. Drug Allergy   : Yes             No 
 Details ---------------- 
Age at first time   : 
diagnosis  
 
Treatment & Dialysis details  : 
General Examination   : 
Build      : 
HT Diabetes 
mellitus  
Renal 
disease 
TB   Others 
     
Smoking  Alcohol Drug Abuse 
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Nutrition     :  
 
 
Anemia  Lymph 
nodes  
Jaundice  Cubbing Cyanosis  Oedema 
 
Temp   pulse    BP   JVP 
Abdomen  
Cardiovascular system    central Nervous System  
 
Respiratory system     Musculoskeletal system  
Skin  
ENT 
Dental  
Opthal  
Investigations  
• Urine Routine  
Date 
Date 
• Urine culture and sensitivity  : 
 
 
Height : 
Weight : BMI 
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• Urine Spot protein /    :  1. 
Creatinine ratio 
        2. 
24 hrs. urine protein  
Date  Blood 
sugar  
Blood 
urea  
Serum 
crea 
tinine  
Na K
 
Serum 
Protein
s 
Albumi
n 
Ca  PO4 Uric 
Acid  
Cholesterol  
        
    
        
 
Cock croft Gault formula :   140- Age x IBW in (kg) 
Serum Creatinine x  72 
(0.85 women) 
CKD stage  
CBC-TC DC Hb ESR 
 
• CT      BT    PT 
 
 
• ECG 
 
• CXR 
 
• Xray KUB 
 
• USG Abdomen / Kidney and Urinary bladder  
• Echo 
• Analysis of Report  
 
Signature of Guide 
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